“Woah! It's like Spotify but for academic articles.”

Instant Access to Thousands of Journals for just $40/month

Get 2 Weeks Free

Acute myocardial infarction in women: is there a sex disparity between door-to-balloon time and clinical outcomes?

Acute myocardial infarction in women: is there a sex disparity between door-to-balloon time and clinical outcomes? Coronary artery disease (CAD) has traditionally been thought of as a disease that predominantly affects men. Women, however, are more likely than men to die from a myocardial infarction (MI). Despite increased awareness of heart disease in women and improved outcomes after percutaneous coronary intervention (PCI), women with MI have more mortality and delays to treatment than men. Although all of the reasons behind these differences are not clear, women presenting with MI are a more morbid patient population than their male counterparts. Women consistently demonstrate higher baseline risk, including older age, higher rates of diabetes mellitus (DM), hypertension (HTN) and congestive heart failure (CHF) [1–5] . This was initially demonstrated in trials conducted in the thrombolytic era, but has persisted in the current era of PCI [3,5] . Another source of sex disparity in ST-elevation MI (STEMI) management is delay to treatment. It is well established that the benefit of PCI over fibrinolytic therapy is lost with delay in administering treatment. A meta-regression analysis of 23 randomized controlled trials in 2003 showed that for every 10-minute delay in PCI (defined as the difference between door to balloon and door to needle), the favorable reduction in mortality is http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cardiovascular Revascularization Medicine Elsevier
Loading next page...
 
/lp/elsevier/acute-myocardial-infarction-in-women-is-there-a-sex-disparity-between-wx8uyBpO4Z

You're reading a free preview. Subscribe to read the entire article.

And millions more from thousands of peer-reviewed journals, for just $40/month

Get 2 Weeks Free

To be the best researcher, you need access to the best research

  • With DeepDyve, you can stop worrying about how much articles cost, or if it's too much hassle to order — it's all at your fingertips. Your research is important and deserves the top content.
  • Read from thousands of the leading scholarly journals from Springer, Elsevier, Nature, IEEE, Wiley-Blackwell and more.
  • All the latest content is available, no embargo periods.

Stop missing out on the latest updates in your field

  • We’ll send you automatic email updates on the keywords and journals you tell us are most important to you.
  • There is a lot of content out there, so we help you sift through it and stay organized.